Author:
Koskinen Hanna,Ahola Elina,Saastamoinen Leena K,Mikkola Hennamari,Martikainen Jaana E
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Health at a glance: Europe 2010. Paris, OECD; 2010.
2. Rietveld AH, Haaijer-Rustkamp FM: Policy options for cost containment of pharmaceuticals. Int J Risk Saf Med 2002, 15: 29–54.
3. Ess SM, Schneeweiss S, Szucs TD: European healthcare policies for controlling drug expenditure. Pharmacoeconomics 2003, 21(2):89–103. 10.2165/00019053-200321020-00002
4. Danzon PM, Ketcham JD: Reference pricing of pharmaceuticals for medicare: evidence from Germany, the Netherlands, and New zealand. Front Health Policy Res 2004, 7: 1–54.
5. Dylst P, Vulto A, Simoens S: The impact of reference-pricing systems in Europe: a literature review and case studies. Expert Rev Pharmacoecon Outcomes Res 2011, 11(6):729–37.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献